![synergy laboratories synergy laboratories](https://cdn.shoplightspeed.com/shops/632076/files/19827184/1600x2048x1/synergy-labs-vf-solutions-ultra-oatmeal-moisturizi.jpg)
Our team is ready to make meaningful contributions to the enlarged group with our technical expertise, especially in the field of lung cancer, as well as firsthand clinical experience. Tony Mok, Chairman of Sanomics, says “We are excited to join the ACT Genomics big family. The combined group will be better able to take advantage of our respective clear leadership positions and form a next generation oncology diagnostics powerhouse with a keen devotion to ESG in Asia.” Hua Chien Chen, CEO of ACT Genomics, says “The union of ACT Genomics and Sanomics will significantly broaden our horizon in terms of product offerings, business strategy and vision. This helps promote a synergistic competitive advantage in serving the medical and pharmaceutical communities on the ground in Asia and Europe.ĭr. The enlarged company has presences in Hong Kong, Taipei, Tokyo, Singapore, Bangkok and the Wales (UK). The group also has a CAP-accredited laboratory in Kanagawa (Japan) under its joint venture with Canon Medical Systems, and one more newly formed laboratory in Taipei under another joint venture with Cerba Research on IHC/Flow Cytometry. The combined group has four wholly owned laboratories, two in Hong Kong, one in Taipei and one in Bangkok, among which three (Hong Kong and Taipei) are CAP-accredited.
![synergy laboratories synergy laboratories](https://images.squarespace-cdn.com/content/v1/5a701541d7bdce4b76095f70/1574233901735-5ISSN4PM0CWP80SOCMTJ/lab.png)
The portfolio also includes services covering cancer types at all different stages in clinical applications as well as assisting pharmaceutical companies in companion diagnostics development and drug discovery.Īccording to GLOBOCAN’s latest cancer statistics, there were an estimated 19.3 million new cancer cases and 9.9 million cancer deaths occurred worldwide in 2020, among which 49.3% of all cases and 58.3% of cancer deaths are estimated to have occurred in Asia.
![synergy laboratories synergy laboratories](https://www.synergylabs.org/assets/static/favicon.c9e37ea.52ac045715c81bf8f5e0570048c02eeb.png)
The next-generation oncology diagnostic powerhouse will offer a wide range of innovative and state-of-the-art products for both tissue and liquid-based tests, multiple diagnostic technology platforms including NGS, digital PCR and gene-chips. The merger is set to create an integrated oncology diagnostic powerhouse in Asia and unleash the global potential of healthcare technology (healthtech) in Hong Kong, the Greater Bay Area and beyond. Both ACT Genomics and Sanomics are park companies of Hong Kong Science and Technology Parks Corporation (HKSTP) and located in the Hong Kong Science Park. I will not order tests without first administering the proper risk assessments to justify medical necessity.(Hong Kong, 22 November 2021) ACT Genomics Holdings Company Limited (“ACT Genomics”), a leading cancer solution provider in Asia, announced today that it has merged with Sanomics Holdings Limited (“Sanomics”), a champion in lung cancer diagnostics in Hong Kong and Thailand. Obtain this documentation from my patients. I acknowledge that it is my responsibility to I understand that documents that may be requested include but are not limited to:Īuthorization of benefits, consent for treatment, advanced beneficiary notice of noncoverage, and/or progress notes. I understand it is my responsibility to properly chart my patients' progress and will provide any applicable information for a patient to Synergy Laboratories upon request if a test hasīeen performed for the requested patient by Synergy Laboratories. I understand it is my responsibility to provide Synergy Laboratories with a signed (ink or digital) copy of any Laboratory Requisition Form and authorize Synergy Laboratories to apply this signature to any requisition form transmitted from my office (either physical or digital) in the event that my health care system cannot apply it during transmission.
#SYNERGY LABORATORIES PROFESSIONAL#
Guidelines set forth by these entities along with my professional judgment to develop individual treatment plans for my patients. The guidelines set forth by state and federal agencies, including but not limited to the Centers for Medicare and Medicaid Services, and agree to utilize the I understand it is my responsibility as a physician to assess my patients' risk factors and order tests based on each specific patient's need(s). I hereby acknowledge that Synergy Laboratories will perform the above requested laboratory testing for patients from my practice as assigned and indicated on individual patient Laboratory Requisition Forms, whether in physical copy or digital.